P. Paty

发表

Comprehensive molecular characterization of human colon and rectal cancer

Steven J. M. Jones, Joshua M. Stuart, Brian D. O’Connor, 2012, Nature.

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

L. Liau, P. Mischel, I. Mellinghoff, 2013, Nature Genetics.

Neuroendocrine Carcinomas of the Colon and Rectum

H. Thaler, J. Guillem, P. Paty, 2004, Diseases of the colon and rectum.

Surgical resection and high dose rate intraoperative radiation therapy for locally recurrent rectal cancer.

J. Guillem, P. Paty, L. Temple, 2004, Acta chirurgica Iugoslavica.

Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer.

P. Paty, K. Subbaramaiah, A. Dannenberg, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Resection of Locally Recurrent Colorectal Cancer in the Presence of Distant Metastases: Can It Be Justified?

J. Hartley, J. Guillem, P. Paty, 2003, Annals of Surgical Oncology.

Abdominal wall recurrence after colorectal resection for cancer

J. Guillem, P. Paty, A. Cohen, 2000, Diseases of the colon and rectum.

Favorable short-term and long-term outcome after elective radical rectal cancer resection in patients 75 years of age or older

H. Thaler, J. Guillem, P. Paty, 2000, Diseases of the colon and rectum.

K-ras mutation in adenomas and carcinomas of the ampulla of vater.

C. Cordon-Cardo, P. Paty, D. Klimstra, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer.

L. Schwartz, M. Gonen, W. Jarnagin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

N. Kemeny, J. Guillem, P. Paty, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Asparagine Metabolism in Tumors Is Linked to Poor Survival in Females with Colorectal Cancer: A Cohort Study

Caroline H. Johnson, N. Ahuja, P. Paty, 2021, medRxiv.

Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer.

M. Gonen, K. Goodman, P. Paty, 2010 .

Squamous-Cell Carcinoma of the Rectum: A Rare but Curable Tumor

Laura H. Tang, J. Guillem, P. Paty, 2007, Diseases of the colon and rectum.

Phenylacetate inhibits isoprenoid biosynthesis and suppresses growth of human pancreatic carcinoma.

P. Paty, P. Paty, M. Brennan, 1998, Surgery.

Elevation of intracellular cyclic adenosine monophosphate inhibits the epidermal growth factor signal transduction pathway and cellular growth in pancreatic adenocarcinoma cell lines.

P. Paty, J. Daly, M. Lieberman, 1996, Surgery.

Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease.

L. Schwartz, W. Jarnagin, P. Paty, 1999, Journal of the American College of Surgeons.

Multivisceral resections for rectal cancer

J. Guillem, G. Nash, P. Paty, 2012, The British journal of surgery.

Response to Neoadjuvant Therapy in Patients With Early Age-of-Onset Rectal Cancer

J. Guillem, G. Nash, P. Paty, 2013, Diseases of the colon and rectum.

Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.

W. Enker, N. Kemeny, J. Guillem, 1997, International journal of radiation oncology, biology, physics.

Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients.

J. Guillem, P. Paty, L. Saltz, 2002, Journal of the American College of Surgeons.

Results After Rectal Cancer Resection With In-Continuity Partial Vaginectomy and Total Mesorectal Excision

J. Guillem, P. Paty, B. Minsky, 2003, Annals of Surgical Oncology.

Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells

P. Paty, P. Paty, D. Wojciechowicz, 1999, British Journal of Cancer.

Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation

J. Guillem, P. Paty, D. Shibata, 2000, Diseases of the colon and rectum.

Conservative management of rectal cancer with local excision and postoperative adjuvant therapy.

J. Guillem, P. Paty, L. Saltz, 1999, International journal of radiation oncology, biology, physics.

Beta 1-6 branching of N-linked carbohydrate is associated with K-ras mutation in human colon carcinoma cell lines.

P. Paty, D. Wojciechowicz, P. Park, 1995, Biochemical and biophysical research communications.

Signet-ring cell carcinoma of the colon and rectum: a matched control study.

J. Guillem, P. Paty, A. Nissan, 1998, Diseases of the colon and rectum.

Complete pathologic response in the primary of rectal or colon cancer treated with FOLFOX without radiation.

K. Goodman, J. Guillem, P. Paty, 2010 .

Mismatch repair deficient rectal cancer is resistant to induction combination chemotherapy.

K. Goodman, J. Guillem, G. Nash, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Goblet cell carcinoid neoplasm of the appendix: clinical and CT features.

J. Guillem, G. Nash, P. Paty, 2013, European journal of radiology.

Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases.

L. Schwartz, M. D'Angelica, W. Jarnagin, 2004, Journal of Clinical Oncology.

CEA for monitoring colon cancer.

P. Paty, A. Cohen, 1994, JAMA.

Automated, multiplex assay for high-frequency microsatellite instability in colorectal cancer.

F. Barany, G. Nash, P. Paty, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis.

D. Notterman, Michal Sheffer, E. Domany, 2007, Cancer research.

T3N0 rectal cancer: Results following sharp mesorectal excision and no adjuvant therapy

W. Enker, J. Guillem, P. Paty, 1999, Journal of Gastrointestinal Surgery.

Radiation-induced gastrointestinal (GI) syndrome as a function of age

P. Paty, A. Haimovitz-Friedman, Z. Fuks, 2015, Cell Death Discovery.

The role of surgery and chemoradiation therapy for cancer of the rectum.

P. Paty, A. Cohen, 1999, Advances in surgery.

Treatment of colorectal cancer: hepatic metastasis.

L H Blumgart, N. Kemeny, P. Paty, 1996, Seminars in surgical oncology.

Effectiveness of a multidisciplinary patient care bundle for reducing surgical‐site infections

M. Gonen, J. Guillem, G. Nash, 2018, The British journal of surgery.

Incisional hernias after laparoscopic and robotic right colectomy

J. Guillem, G. Nash, P. Paty, 2016, Hernia.

Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective

P. Paty, G. Poultsides, 2011, Therapeutic advances in medical oncology.

Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients.

J. Guillem, P. Paty, L. Harrison, 1997, Journal of the American College of Surgeons.

GROα Is Highly Expressed in Adenocarcinoma of the Colon and Down-Regulates Fibulin-1

D. Notterman, W. Gerald, F. Barany, 2006, Clinical Cancer Research.

American Society of Colon and Rectal Surgeons 91st Annual Convention Podium and Poster abstracts

P. M. Falk, L. K. Harding, T. G. Perry, 1992 .

CEA is the major PHA-L-reactive glycoprotein in colon carcinoma cell lines and tumors: relationship between K-ras activation and beta1-6 branching of N-linked carbohydrate on CEA.

P. Paty, D. Wojciechowicz, P. Park, 2000, Biochemical and biophysical research communications.

Characterization of lectin resistant cell populations derived from human colon carcinoma: correlation of K-Ras with beta1-6 branching of N-linked carbohydrate and CEA production.

P. Paty, D. Wojciechowicz, R. Mallon, 1999, Biochemical and biophysical research communications.

Phytohemagglutinin-L (PHA-L) lectin surface binding of N-linked beta 1-6 carbohydrate and its relationship to activated mutant ras in human pancreatic cancer cell lines.

P. Paty, P. Paty, D. Wojciechowicz, 1996, Cancer letters.

Signet-ring cell carcinoma of the colon and rectum

J. Guillem, P. Paty, A. Nissan, 1999 .

Stage I rectal cancer: identification of high-risk patients.

J. Guillem, P. Paty, D. Klimstra, 1998, Journal of the American College of Surgeons.

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

N. Kemeny, J. Guillem, P. Paty, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers.

B. Taylor, N. Schultz, K. Offit, 2021, Journal of the National Cancer Institute.

Young Age Influences Treatment but not Outcome of Colon Cancer

J. Guillem, P. Paty, L. Temple, 2007, Annals of Surgical Oncology.

Sphincter preservation in rectal cancer. Technical considerations for coloanal anastomosis and J-pouch.

P. Paty, A. Cohen, 1998, Seminars in radiation oncology.

The adenoma carcinoma sequence in colorectal neoplasia.

P. Paty, A. Cohen, 1993, Der Gastroenterologe.

Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer

M. Weiser, L. Schwartz, O. Akin, 2012, European Radiology.

Liver resection after hepatic arterial infusion (HAI) plus systemic oxaliplatin (Oxal) combinations in pretreated patients with extensive unresectable colorectal liver metastases

L. Schwartz, M. D'Angelica, W. Jarnagin, 2004 .

Prognostic Aspects of DCE-MRI in Recurrent Rectal Cancer

L. Schwartz, M. Gonen, K. Goodman, 2013, European Radiology.

Wheatgerm agglutinin-mediated toxicity in pancreatic cancer cells.

P. Paty, P. Paty, D. Wojciechowicz, 1999 .

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

N. Kemeny, J. Guillem, P. Paty, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative radiation with or without chemotherapy and full-thickness transanal excision for selected T2 and T3 distal rectal cancers

J. Guillem, P. Paty, P. Paty, 2002, International Journal of Colorectal Disease.

Preoperative evaluation and postoperative follow-up for patients with rectal cancer.

P. Paty, W. Wong, 2004, Acta chirurgica Iugoslavica.